🇫🇷
France · FR · FR:62099847
GEMCITABINE KABI 38 mg/mL, solution à diluer pour perfusion
ATC L01BC05
Last synced from Base de données publique des médicaments — BDPM (France) on
Identification
ManufacturerFRESENIUS KABI FRANCE
CountryFR (France)
ATC codeL01BC05
Dispensing—
ReimbursedNo
SourceBase de données publique des médicaments — BDPM (France)
Last synced6/3/2026
Packs · 2
- cip1334009550013791 flacon(s) en verre de 26,3 ml
- cip1334009550013931 flacon(s) en verre de 52,6 ml
Annotations
No annotations yet.
Raw payload (JSON)
{
"cis": "62099847",
"date_amm": "2016-04-25",
"type_amm": "Procédure décentralisée",
"numero_ue": null,
"statut_amm": "Autorisation active",
"statut_bdm": "Warning disponibilité",
"forme_pharmaceutique": "solution à diluer pour perfusion",
"voies_administration": "intraveineuse",
"etat_commercialisation": "Non commercialisée",
"surveillance_renforcee": "Non"
}Related drugs
Other records sharing ATC code L01BC05.
- 🇺🇸AVGEMSIAvyxa Pharma, LLC
- 🇺🇸AVGEMSIAvyxa Pharma, LLC
- DKGemcitabin "Accord"Accord Healthcare B.V.
- DKGemcitabin "Sandoz"Sandoz A/S
- DKGemcitabin "SUN"SUN Pharmaceutical Industries Europe BV
- 🇨🇭Gemcitabin AccordAccord Healthcare AG
- 🇨🇭Gemcitabin AccordAccord Healthcare AG
- 🇨🇭Gemcitabin AccordAccord Healthcare AG
Access this data programmatically
Query GEMCITABINE KABI 38 mg/mL, solution à diluer pour perfusion and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.